T

T2 Biosystems
D

TTOO

0.34900
USD
0.02
(5.44%)
Market Closed
Volume
2,300
EPS
-4
Div Yield
-
P/E
-12
Market Cap
7,343,990
OverviewSignalsIdeasNews
Related Instruments
    ABT
    ABT
    1.790
    (1.59%)
    114.220 USD
    A
    ALGN
    -2.420
    (-1.13%)
    211.130 USD
    B
    BAX
    0.605
    (2.09%)
    29.525 USD
    BDX
    BDX
    4.000
    (1.79%)
    227.810 USD
    BSX
    BSX
    0.320
    (0.36%)
    88.990 USD
    EW
    EW
    0.910
    (1.23%)
    74.820 USD
    ISRG
    ISRG
    1.09
    (0.21%)
    524.91 USD
    MDT
    MDT
    1.030
    (1.29%)
    81.020 USD
    WST
    WST
    4.38
    (1.34%)
    331.51 USD
    ZBH
    ZBH
    1.260
    (1.19%)
    107.050 USD
    More
News

Title: T2 Biosystems

Sector: Healthcare
Industry: Diagnostics & Research
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.